Mante, Friend Rezel C.

HRN: 20-42-64  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
CEFTRIAXONE 1G (VIAL)
03/25/2024
04/01/2024
IV DRIP
1g
Q24
Cfc; TC Uti
Waiting Final Action 
03/28/2024
MUPIROCIN 2%, 15G (TUBE)
03/28/2024
04/04/2024
TOPICAL
15g
BID
Phlebitis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: